SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-000771
Filing Date
2024-05-14
Accepted
2024-05-14 06:32:20
Documents
50
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q clrb-20240331x10q.htm   iXBRL 10-Q 839519
2 EX-31.1 clrb-20240331xex31d1.htm EX-31.1 11070
3 EX-31.2 clrb-20240331xex31d2.htm EX-31.2 11529
4 EX-32.1 clrb-20240331xex32d1.htm EX-32.1 9052
  Complete submission text file 0001410578-24-000771.txt   3867936

Data Files

Seq Description Document Type Size
5 EX-101.SCH clrb-20240331.xsd EX-101.SCH 28417
6 EX-101.CAL clrb-20240331_cal.xml EX-101.CAL 27862
7 EX-101.DEF clrb-20240331_def.xml EX-101.DEF 148095
8 EX-101.LAB clrb-20240331_lab.xml EX-101.LAB 235991
9 EX-101.PRE clrb-20240331_pre.xml EX-101.PRE 217300
54 EXTRACTED XBRL INSTANCE DOCUMENT clrb-20240331x10q_htm.xml XML 497116
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36598 | Film No.: 24941383
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)